Euclid Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-63,647
| Closed | -$4.68M | – | 82 |
|
|
2016
Q2 | $4.68M | Buy |
63,647
+31,530
| +98% | +$2.32M | 0.2% | 172 |
|
|
2016
Q1 | $2.05M | Sell |
32,117
-56,514
| -64% | -$3.61M | 0.08% | 276 |
|
|
2015
Q4 | $6.1M | Buy |
+88,631
| New | +$6.1M | 0.19% | 166 |
|
|
2015
Q3 | – | Sell |
-132,950
| Closed | -$8.85M | – | 252 |
|
|
2015
Q2 | $8.85M | Sell |
132,950
-475,030
| -78% | -$31.6M | 0.17% | 187 |
|
|
2015
Q1 | $39.2M | Buy |
+607,980
| New | +$39.2M | 0.72% | 28 |
|
|
2014
Q4 | – | Sell |
-847,460
| Closed | -$43.4M | – | 385 |
|
|
2014
Q3 | $43.4M | Buy |
847,460
+53,240
| +7% | +$2.72M | 0.31% | 69 |
|
|
2014
Q2 | $38.5M | Sell |
794,220
-117,817
| -13% | -$5.72M | 0.27% | 90 |
|
|
2014
Q1 | $47.4M | Buy |
912,037
+249,000
| +38% | +$12.9M | 0.36% | 61 |
|
|
2013
Q4 | $35.2M | Sell |
663,037
-34,090
| -5% | -$1.81M | 0.29% | 73 |
|
|
2013
Q3 | $32.3M | Buy |
697,127
+145,837
| +26% | +$6.75M | 0.33% | 69 |
|
|
2013
Q2 | $24.6M | Buy |
+551,290
| New | +$24.6M | 0.31% | 76 |
|